Alyeska Investment Group’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$96.4M Sell
558,633
-86,093
-13% -$16M 0.27% 103
2025
Q4
$129M Buy
644,726
+352,549
+121% +$64M 0.36% 68
2025
Q3
$45.7M Sell
292,177
-535
-0.2% -$85K 0.14% 183
2025
Q2
$44.4M Buy
+292,712
New +$39M 0.16% 171
2025
Q1
Sell
-200,262
Closed -$37M 538
2024
Q4
$37M Buy
+200,262
New +$38.6M 0.14% 181
2022
Q4
Sell
-333,429
Closed -$65.6M 435
2022
Q3
$65.6M Buy
333,429
+90,737
+37% +$19.6M 0.77% 30
2022
Q2
$51.9M Buy
242,692
+126
+0.1% +$30.8K 0.6% 40
2022
Q1
$68.9M Buy
242,566
+52,319
+28% +$16.1M 0.76% 26
2021
Q4
$71.7M Buy
190,247
+79,335
+72% +$30.8M 0.83% 23
2021
Q3
$45.8M Buy
110,912
+49,937
+82% +$20.7M 0.57% 43
2021
Q2
$22.6M Buy
+60,975
New +$20.4M 0.26% 115
2020
Q3
Sell
-80,305
Closed -$14M 487
2020
Q2
$14M Buy
+80,305
New +$12.8M 0.22% 154
2020
Q1
Sell
-396,692
Closed -$60.6M 390
2019
Q4
$60.6M Buy
396,692
+157,716
+66% +$21.8M 0.81% 33
2019
Q3
$31.6M Buy
238,976
+93,093
+64% +$12.5M 0.47% 80
2019
Q2
$20.7M Buy
+145,883
New +$19.8M 0.27% 118
2018
Q4
Sell
-171,388
Closed -$23.1M 385
2018
Q3
$23.1M Sell
171,388
-328,488
-66% -$40.5M 0.26% 115
2018
Q2
$56.1M Sell
499,876
-117,928
-19% -$12.7M 0.52% 71
2018
Q1
$65.9M Buy
+617,804
New +$66.6M 0.58% 61
2017
Q3
Sell
-575,439
Closed -$58.2M 473
2017
Q2
$58.2M Sell
575,439
-171,037
-23% -$15.7M 0.5% 75
2017
Q1
$67.1M Sell
746,476
-99,848
-12% -$8.48M 0.55% 53
2016
Q4
$64.5M Buy
846,324
+254,519
+43% +$19.3M 0.54% 52
2016
Q3
$49.3M Sell
591,805
-2,624
-0.4% -$220K 0.46% 63
2016
Q2
$49M Buy
594,429
+18,194
+3% +$1.5M 0.46% 76
2016
Q1
$43.8M Buy
576,235
+543,253
+1,647% +$40.2M 0.4% 83
2015
Q4
$2.65M Buy
+32,982
New +$2.38M 0.03% 288
2014
Q2
Sell
-317,053
Closed -$19.1M 413
2014
Q1
$19.1M Sell
317,053
-32,947
-9% -$1.92M 0.69% 62
2013
Q4
$18.6M Buy
350,000
+50,000
+17% +$2.51M 0.88% 31
2013
Q3
$13.9M Buy
+300,000
New +$13.8M 0.78% 58

Other funds holding CRL